U.S. support of global HIV/AIDS programming is leading the world toward continued remarkable progress against the epidemic. Linking people living with HIV to care and treatment services is critical to reaching those goals, as scientific research has conclusively shown that putting individuals on treatment is not only good for their own health, but also reduces the likelihood of transmission to others.
PEPFAR is the largest commitment by a single nation to combat a single disease globally. Since President Bush’s announcement of PEPFAR in 2003, the U.S. has invested more than $54 billion in bilateral HIV/AIDS programs as well as provided over $12 billion to the Global Fund. As of the end of Fiscal Year (FY) 2015, U.S. assistance supported more than 9.5 million patients on lifesaving antiretroviral treatment and more than 68.2 million people with counseling and testing programs.
Founded in 2002, the Global Fund is a partnership between governments, civil society, the private sector, and people affected by HIV/AIDS, tuberculosis, and malaria. The Global Fund partnership has saved 20 million lives since 2002 and is on track to reach 22 million lives saved by the end of 2016. The Global Fund raises and invests nearly $4 billion a year to support programs run by local experts in countries and communities most in need. Since 2002, in countries where the Global Fund invests, there has been a decline of one-third in the number of people dying from these three diseases. The U.S. government’s financial contribution to the Global Fund continues to be one of the most effective tools for leveraging additional resources for the fight against HIV/AIDS, tuberculosis, and malaria. The U.S. has historically pledged to contribute $1 for every $2 provided by other donors. For the Global Fund’s Fifth Replenishment period – 2017-2019 – the U.S. pledged to contribute $1 for every $2 provided by other donors worldwide through September 30, 2017, up to $4.3 billion.
The U.S. and international partners have greatly scaled up the services to help HIV-positive women to have HIV-negative children: over 75% of HIV-positive women received the necessary treatment and services to reduce transmission from mother to child, resulting in a 70% reduction in new infections since 2000. PEPFAR provided resources and funding for the prevention of mother-to-child HIV transmission for more than 14.7 million HIV-positive pregnant women, allowing more than 267,000 infants to be born HIV-free in FY2015, cumulating in over 1.5 million infections averted in children due to PEPFAR support. And as of the end of 2015, programs supported by the Global Fund provided antiretroviral HIV treatment to 9.2 million people. The number of HIV-positive women who have received services since 2002 to prevent transmission of HIV to their unborn children has reached 3.6 million.
U.S. investment in HIV/AIDS and global health programs strengthens our national security and helps safeguard the health of Americans. A recent study showed that because PEPFAR is “targeted, sustained, effective, and visible,” it has significantly improved public perceptions of the U.S. across many developing countries. The sustainable, long-term approach to laboratory infrastructure and human capacity development has enabled governments and the public to respond to other diseases, such as Ebola in West Africa and the Democratic Republic of Congo. We are seeing recipient countries increase their investments for HIV/AIDS and other health programs, resulting in increased sustainability in fighting their own epidemics. In 2014, domestic investment from low- and middle-income countries accounted for over half of all HIV-related spending.